1. Su S, Wong G, Shi W, Liu J, Lai ACK, Zhou J, et al. Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses. Trends in microbiology. 2016;24(6):490-502. [DOI:10.1016/j.tim.2016.03.003] [PMID] []

2. Channappanavar R, Perlman S. Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology. Seminars in immunopathology. 2017;39(5):529-39. [DOI:10.1007/s00281-017-0629-x] [PMID] []

3. Jiang F, Deng L, Zhang L, Cai Y, Cheung CW, Xia Z. Review of the Clinical Characteristics of Coronavirus Disease 2019 (COVID-19). Journal of general internal medicine. 2020;35(5):1545-9. [DOI:10.1007/s11606-020-05762-w] [PMID] []

4. Lai CC, Shih TP, Ko WC, Tang HJ, Hsueh PR. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. International journal of antimicrobial agents. 2020;55(3):105924. [DOI:10.1016/j.ijantimicag.2020.105924] [PMID] []

5. Park SE. Epidemiology, virology, and clinical features of severe acute respiratory syndrome -coronavirus-2 (SARS-CoV-2; Coronavirus Disease-19). Clinical and experimental pediatrics. 2020;63(4):119-24. [DOI:10.3345/cep.2020.00493] [PMID] []

6. Zimmermann P, Curtis N. Coronavirus Infections in Children Including COVID-19: An Overview of the Epidemiology, Clinical Features, Diagnosis, Treatment and Prevention Options in Children. The Pediatric infectious disease journal. 2020;39(5):355-68. [DOI:10.1097/INF.0000000000002660] [PMID] []

7. Ganji A, Mosayebi G, Khaki M, Ghazavi A. A Review of the 2019 Novel Coronavirus (Covid-19): Immunopathogenesis, Molecular Biology and Clinical Aspects. Journal of Arak University of Medical Sciences. 2020;23(1):8-21. [DOI:10.32598/JAMS.23.1.51.5]

8. Ghasemzadeh F, Arab-kheradmand A, Daklan S, Shabaninezhad A, Garajei A, Etminani K. Determination of the Most Important Factors Affecting Non-Melanoma Skin Cancer Using Data Mining Algorithms. Journal of Health and Biomedical Informatics. 2017;4(1):39-47.

9. Galván Casas C, Català A, Carretero Hernández G, Rodríguez-Jiménez P, Fernández-Nieto D, Rodríguez-Villa Lario A, et al. Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases. The British journal of dermatology. 2020;183(1):71-7. [DOI:10.1111/bjd.19163] [PMID] []

10. Marzano AV, Genovese G, Moltrasio C, Gaspari V, Vezzoli P, Maione V, et al. The clinical spectrum of COVID-19-associated cutaneous manifestations: An Italian multicenter study of 200 adult patients. Journal of the American Academy of Dermatology. 2021;84(5):1356-63. [DOI:10.1016/j.jaad.2021.01.023] [PMID] []

11. Iranmanesh B, Khalili M, Amiri R, Zartab H, Aflatoonian M. Oral manifestations of COVID-19 disease: A review article. Dermatologic therapy. 2021;34(1):e14578. [DOI:10.1111/dth.14578] []

12. Dalal A, Jakhar D, Agarwal V, Beniwal R. Dermatological findings in SARS-CoV-2 positive patients: An observational study from North India. Dermatologic therapy. 2020;33(6):e13849. [DOI:10.1111/dth.13849] [PMID] []

13. Eastin C, Eastin T. Clinical Characteristics of Coronavirus Disease 2019 in China: Guan W, Ni Z, Hu Y, et al. N Engl J Med. 2020 Feb 28. [DOI:10.1016/j.jemermed.2020.04.004] []

14. Recalcati S. Cutaneous manifestations in COVID-19: a first perspective. Journal of the European Academy of Dermatology and Venereology : JEADV. 2020;34(5):e212-e3. [DOI:10.1111/jdv.16387] []

15. Giavedoni P, Podlipnik S, Pericàs JM, Fuertes de Vega I, García-Herrera A, Alós L, et al. Skin Manifestations in COVID-19: Prevalence and Relationship with Disease Severity. Journal of clinical medicine. 2020;9(10). [DOI:10.3390/jcm9103261] [PMID] []

16. Askin O, Altunkalem RN, Altinisik DD, Uzuncakmak TK, Tursen U, Kutlubay Z. Cutaneous manifestations in hospitalized patients diagnosed as COVID-19. Dermatologic therapy. 2020;33(6):e13896. [DOI:10.1111/dth.13896]

17. Palanisamy PR, Elango D. COVID19 associated mucormycosis: A review. Journal of family medicine and primary care. 2022;11(2):418-23. [DOI:10.4103/jfmpc.jfmpc_1186_21] [PMID] []

18. Yang X, Yu Y, Xu J, Shu H, Xia Ja, Liu H, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. The Lancet Respiratory Medicine. 2020;8(5):475-81. [DOI:10.1016/S2213-2600(20)30079-5] [PMID]